Faulty genes that cause heart disease focus of personalized medicine

e cc z
Credit: Nicolas Raymond

The human genome project began a decade of advancement in personalized medicine. Sequencing large amounts of genetic material has made many diseases easier to identify and treat, none more so than cancer.

Most cancer patients now have their tumors genetically analyzed. That information helps oncologists pinpoint whether radiation or which specific types of chemotherapy agents will best treat their tumor type. In fact, some specialists think within the next decades, we will stop identifying cancers by location (breast, skin, prostate) and instead describe them by their genetic characteristics.

Heart disease is not far behind, says Elizabeth McNally, director of the cardiovascular genetics clinic at University of Chicago. So far, genes have been identified for heart failure, cardiomyopathy, congenital heart disease, arrhythmias and vascular disease and subtypes of these diseases, McNally wrote in Science Translational Medicine:

The payoff is clear: a precise genetic diagnosis for the individual patient which helps influence the choice of treatment. The same genetic information is also a diagnostic tool for family members to determine who is at risk for developing disease.

Ultimately, she says, cardiac disease will be treated by correcting these faulty genes.

Additional resources:

 

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend